降温深度与持续时间对缺氧缺血性脑病新生儿18月龄死亡或残疾的影响:一项随机临床试验
这项2×2析因随机临床试验纳入364名胎龄≥36周的缺氧缺血性脑病新生儿,比较33.5°C或32.0°C降温72小时或120小时对18至22月龄死亡或中重度残疾的影响。结果显示延长至120小时或降至32.0°C均未减少死亡或残疾,且观察到更长与更深降温之间存在显著交互作用(P=.048),结果支持当前72小时33.5°C的降温方案。
要点
- 在364名缺氧缺血性脑病新生儿中,120小时降温与72小时相比死亡或残疾率无显著差异。
- 32.0°C降温与33.5°C相比死亡或残疾率无显著差异。
- 更长与更深降温之间存在显著交互作用(P=.048),结果支持当前72小时33.5°C方案。
核心结论
- 在足月中重度缺氧缺血性脑病新生儿中,降温超过72小时、降至低于33.5°C或两者兼有均未减少18月龄时死亡或中重度残疾。
- 该试验可能把握度不足,且发现更长与更深降温之间存在交互作用;这些结果支持当前72小时33.5°C的降温方案。
研究设计与样本
- 随机2×2析因临床试验,纳入胎龄≥36周的缺氧缺血性脑病新生儿,来自美国18个中心,隶属于Eunice Kennedy Shriver国家儿童健康与人类发展研究所新生儿研究网络,时间段为2010年10月至2016年1月。
- 共364名新生儿随机分配至4个低温组:33.5°C持续72小时(n=95)、32.0°C持续72小时(n=90)、33.5°C持续120小时(n=96)、32.0°C持续120小时(n=83)。
- 主要结局为18至22月龄时死亡或中重度残疾,按中心和脑病程度校正。
- 试验在入组364名(计划726名)后于2013年11月因安全性和无效性提前终止。
- 347名(95%)婴儿有主要结局数据(随访平均年龄20.7月,标准差3.5月;42%为女性)。
主要发现
- 降温72小时组176例中56例(31.8%)发生死亡或残疾,降温120小时组171例中54例(31.6%)发生(校正风险比0.92,95%CI 0.68-1.25;校正绝对风险差-1.0%,95%CI -10.2%至8.1%)。
- 降温至33.5°C组185例中59例(31.9%)发生死亡或残疾,降温至32.0°C组162例中51例(31.5%)发生(校正风险比0.92,95%CI 0.68-1.26;校正绝对风险差-3.1%,95%CI -12.3%至6.1%)。
- 观察到更长与更深降温之间存在显著交互作用(P=.048),主要结局发生率分别为:33.5°C持续72小时组29.3%、32.0°C持续72小时组34.5%、33.5°C持续120小时组34.4%、32.0°C持续120小时组28.2%。
关键数值与推荐
- 严重残疾包括以下任一:Bayley婴幼儿发育量表第三版认知评分低于70、粗大运动功能分类系统(GMFCS)3至5级、或即使使用放大设备仍失明或听力丧失。
- 中度残疾定义为认知评分70至84,且满足以下任一:GMFCS 2级、活动性癫痫发作、或需助听器听力。
临床怎么用
- 作者结论认为这些结果支持当前72小时33.5°C的降温方案。
局限性
- 试验可能把握度不足。
- 试验在入组364名(计划726名)后因安全性和无效性提前终止。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hypothermia for 72 hours at 33.5°C for neonatal hypoxic-ischemic encephalopathy reduces death or disability, but rates continue to be high. OBJECTIVE: To determine if cooling for 120 hours or to a temperature of 32.0°C reduces death or disability at age 18 months in infants with hypoxic-ischemic encephalopathy. DESIGN, SETTING, AND PARTICIPANTS: Randomized 2 × 2 factorial clinical trial in neonates (≥36 weeks' gestation) with hypoxic-ischemic encephalopathy at 18 US centers in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network between October 2010 and January 2016. INTERVENTIONS: A total of 364 neonates were randomly assigned to 4 hypothermia groups: 33.5°C for 72 hours (n = 95), 32.0°C for 72 hours (n = 90), 33.5°C for 120 hours (n = 96), or 32.0°C for 120 hours (n = 83). MAIN OUTCOMES AND MEASURES: The primary outcome was death or moderate or severe disability at 18 to 22 months of age adjusted for center and level of encephalopathy. Severe disability included any of Bayley Scales of Infant Development III cognitive score less than 70, Gross Motor Function Classification System (GMFCS) level of 3 to 5, or blindness or hearing loss despite amplification. Moderate disability was defined as a cognitive score of 70 to 84 and either GMFCS level 2, active seizures, or hearing with amplification. RESULTS: The trial was stopped for safety and futility in November 2013 after 364 of the planned 726 infants were enrolled. Among 347 infants (95%) with primary outcome data (mean age at follow-up, 20.7 [SD, 3.5] months; 42% female), death or disability occurred in 56 of 176 (31.8%) cooled for 72 hours and 54 of 171 (31.6%) cooled for 120 hours (adjusted risk ratio, 0.92 [95% CI, 0.68-1.25]; adjusted absolute risk difference, -1.0% [95% CI, -10.2% to 8.1%]) and in 59 of 185 (31.9%) cooled to 33.5°C and 51 of 162 (31.5%) cooled to 32.0°C (adjusted risk ratio, 0.92 [95% CI, 0.68-1.26]; adjusted absolute risk difference, -3.1% [95% CI, -12.3% to 6.1%]). A significant interaction between longer and deeper cooling was observed (P = .048), with primary outcome rates of 29.3% at 33.5°C for 72 hours, 34.5% at 32.0°C for 72 hours, 34.4% at 33.5°C for 120 hours, and 28.2% at 32.0°C for 120 hours. CONCLUSIONS AND RELEVANCE: Among term neonates with moderate or severe hypoxic-ischemic encephalopathy, cooling for longer than 72 hours, cooling to lower than 33.5°C, or both did not reduce death or moderate or severe disability at 18 months of age. However, the trial may be underpowered, and an interaction was found between longer and deeper cooling. These results support the current regimen of cooling for 72 hours at 33.5°C. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01192776.
引用
- Shankaran S, Laptook AR, Pappas A, et al. Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial. JAMA. 2017. PMID: 28672318. doi:10.1001/jama.2017.7218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。